AMERICAN JOURNAL OF ROENTGENOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=834534, encodeId=4825834534fd, content=投稿2个月给意见，修回2个月接收，有点慢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f725414123, createdName=ms5659675100501325, createdTime=Thu Nov 10 11:07:25 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530519, encodeId=48bd5305198f, content=投稿网址能发我一下吗？第一次投外文没经验350779123 2016-03-18 发表:: 研究方向：影像;新技术; 接收率：约50% 审稿时间：约3个月投了一篇，2个月后大修，刚提交了修改稿，虽然审稿人希望提的意见挺难回答的，希望能中~~~, beContent=350779123 2016-03-18 发表:: 研究方向：影像;新技术; 接收率：约50% 审稿时间：约3个月投了一篇，2个月后大修，刚提交了修改稿，虽然审稿人希望提的意见挺难回答的，希望能中~~~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c8825317, createdName=fumingcui, createdTime=Tue Dec 13 11:20:00 CST 2016, time=2016-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086526, encodeId=2b8a108652684, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086525, encodeId=b5bf1086525ad, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978766, encodeId=21589e876627, content=请问各位投稿时的Author disclosures是什么意思呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58865518742, createdName=ms4000001092197071, createdTime=Thu Jul 01 21:14:47 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555987, encodeId=97d455598e9c, content=这篇杂志能共一吗?能有共同通讯吗?zhangxin19830818 2018-04-13 10:15:00 发表: 这个杂志很负责人.对中国学子很友好.我想说我的第一篇SCI文章投的就是这个杂志.2个月被拒了.但是. 一个审稿专家给出了22页的审稿意见.连论文题目都给我重写了.其他精确到每个文字错误.然后改投其同类级别2分多的杂志.直接接受., beContent=zhangxin19830818 2018-04-13 10:15:00 发表: 这个杂志很负责人.对中国学子很友好.我想说我的第一篇SCI文章投的就是这个杂志.2个月被拒了.但是. 一个审稿专家给出了22页的审稿意见.连论文题目都给我重写了.其他精确到每个文字错误.然后改投其同类级别2分多的杂志.直接接受., objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/20/b91b19438f6b5b9d4690ac1c6d87b0b3.jpg, createdBy=e9bd2178983, createdName=阳阳～, createdTime=Fri May 11 00:00:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554930, encodeId=0bd155493050, content=这个杂志很负责人，对中国学子很友好，我想说我的第一篇SCI文章投的就是这个杂志，2个月被拒了，但是，一个审稿专家给出了22页的审稿意见，连论文题目都给我重写了，其他精确到每个文字错误。然后改投其同类级别2分多的杂志，直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/55de70b000754a05b1e4421732bd1c69/6338f0fa024349e1b0ef32e05975b7a6.jpg, createdBy=8f471417716, createdName=zhangxin19830818, createdTime=Fri Apr 13 10:15:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538884, encodeId=d0dc538884d8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿非常慢，投过去后先一个月放那不动；外审一个月；给3个月时间修改，总共5个月接收。 现在接收三个多月了，还没online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eocSnxm7sxxUDwqzdJ3v2akxES9nNYZx70Cy5jLh29SyNnreINBwFwbY3ZOfBF9wSiaiaCnXqddzW1Q/132, createdBy=ae061713092, createdName=Huge502a03ace, createdTime=Tue Jul 18 09:30:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537442, encodeId=267b53e4421c, content=请问，AJR的版面费是多少呢？raindrop 2016-11-16 发表:: 研究方向：基础;; 接收率：约50% 审稿时间：约2个月第一次投稿很幸运的接受了。2个月后初审有结果，大修2次，最终接受一共4个月。专家意见比较中肯，相对友好。感觉偏基础，有一定的新意就可以。, beContent=raindrop 2016-11-16 发表:: 研究方向：基础;; 接收率：约50% 审稿时间：约2个月第一次投稿很幸运的接受了。2个月后初审有结果，大修2次，最终接受一共4个月。专家意见比较中肯，相对友好。感觉偏基础，有一定的新意就可以。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIWznAvf9w9JibPNFEeoqCfBIyP39d1HicA7Bpia7v2ACoE1zDx8xMjD7e26gNNydnwKfrOIT6ycrQUw/0, createdBy=e3842049169, createdName=弥夏兰卡, createdTime=Tue Jun 06 11:55:00 CST 2017, time=2017-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836092, encodeId=9c1d83609247, content=几乎没有什么中国人的文章，不要投了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7055413998, createdName=ms1387707191880519, createdTime=Sat Apr 01 16:03:54 CST 2017, time=2017-04-01, status=1, ipAttribution=)]

2016-11-10 ms5659675100501325

投稿2个月给意见，修回2个月接收，有点慢

104 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=834534, encodeId=4825834534fd, content=投稿2个月给意见，修回2个月接收，有点慢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f725414123, createdName=ms5659675100501325, createdTime=Thu Nov 10 11:07:25 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530519, encodeId=48bd5305198f, content=投稿网址能发我一下吗？第一次投外文没经验350779123 2016-03-18 发表:: 研究方向：影像;新技术; 接收率：约50% 审稿时间：约3个月投了一篇，2个月后大修，刚提交了修改稿，虽然审稿人希望提的意见挺难回答的，希望能中~~~, beContent=350779123 2016-03-18 发表:: 研究方向：影像;新技术; 接收率：约50% 审稿时间：约3个月投了一篇，2个月后大修，刚提交了修改稿，虽然审稿人希望提的意见挺难回答的，希望能中~~~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c8825317, createdName=fumingcui, createdTime=Tue Dec 13 11:20:00 CST 2016, time=2016-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086526, encodeId=2b8a108652684, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086525, encodeId=b5bf1086525ad, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978766, encodeId=21589e876627, content=请问各位投稿时的Author disclosures是什么意思呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58865518742, createdName=ms4000001092197071, createdTime=Thu Jul 01 21:14:47 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555987, encodeId=97d455598e9c, content=这篇杂志能共一吗?能有共同通讯吗?zhangxin19830818 2018-04-13 10:15:00 发表: 这个杂志很负责人.对中国学子很友好.我想说我的第一篇SCI文章投的就是这个杂志.2个月被拒了.但是. 一个审稿专家给出了22页的审稿意见.连论文题目都给我重写了.其他精确到每个文字错误.然后改投其同类级别2分多的杂志.直接接受., beContent=zhangxin19830818 2018-04-13 10:15:00 发表: 这个杂志很负责人.对中国学子很友好.我想说我的第一篇SCI文章投的就是这个杂志.2个月被拒了.但是. 一个审稿专家给出了22页的审稿意见.连论文题目都给我重写了.其他精确到每个文字错误.然后改投其同类级别2分多的杂志.直接接受., objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/20/b91b19438f6b5b9d4690ac1c6d87b0b3.jpg, createdBy=e9bd2178983, createdName=阳阳～, createdTime=Fri May 11 00:00:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554930, encodeId=0bd155493050, content=这个杂志很负责人，对中国学子很友好，我想说我的第一篇SCI文章投的就是这个杂志，2个月被拒了，但是，一个审稿专家给出了22页的审稿意见，连论文题目都给我重写了，其他精确到每个文字错误。然后改投其同类级别2分多的杂志，直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/55de70b000754a05b1e4421732bd1c69/6338f0fa024349e1b0ef32e05975b7a6.jpg, createdBy=8f471417716, createdName=zhangxin19830818, createdTime=Fri Apr 13 10:15:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538884, encodeId=d0dc538884d8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿非常慢，投过去后先一个月放那不动；外审一个月；给3个月时间修改，总共5个月接收。 现在接收三个多月了，还没online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eocSnxm7sxxUDwqzdJ3v2akxES9nNYZx70Cy5jLh29SyNnreINBwFwbY3ZOfBF9wSiaiaCnXqddzW1Q/132, createdBy=ae061713092, createdName=Huge502a03ace, createdTime=Tue Jul 18 09:30:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537442, encodeId=267b53e4421c, content=请问，AJR的版面费是多少呢？raindrop 2016-11-16 发表:: 研究方向：基础;; 接收率：约50% 审稿时间：约2个月第一次投稿很幸运的接受了。2个月后初审有结果，大修2次，最终接受一共4个月。专家意见比较中肯，相对友好。感觉偏基础，有一定的新意就可以。, beContent=raindrop 2016-11-16 发表:: 研究方向：基础;; 接收率：约50% 审稿时间：约2个月第一次投稿很幸运的接受了。2个月后初审有结果，大修2次，最终接受一共4个月。专家意见比较中肯，相对友好。感觉偏基础，有一定的新意就可以。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIWznAvf9w9JibPNFEeoqCfBIyP39d1HicA7Bpia7v2ACoE1zDx8xMjD7e26gNNydnwKfrOIT6ycrQUw/0, createdBy=e3842049169, createdName=弥夏兰卡, createdTime=Tue Jun 06 11:55:00 CST 2017, time=2017-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836092, encodeId=9c1d83609247, content=几乎没有什么中国人的文章，不要投了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7055413998, createdName=ms1387707191880519, createdTime=Sat Apr 01 16:03:54 CST 2017, time=2017-04-01, status=1, ipAttribution=)]

2016-12-13 fumingcui

投稿网址能发我一下吗？第一次投外文没经验350779123 2016-03-18 发表::
研究方向：影像;新技术; 接收率：约50% 审稿时间：约3个月投了一篇，2个月后大修，刚提交了修改稿，虽然审稿人希望提的意见挺难回答的，希望能中~~~

350779123 2016-03-18 发表:: 研究方向：影像;新技术; 接收率：约50% 审稿时间：约3个月投了一篇，2个月后大修，刚提交了修改稿，虽然审稿人希望提的意见挺难回答的，希望能中~~~

366 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=834534, encodeId=4825834534fd, content=投稿2个月给意见，修回2个月接收，有点慢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f725414123, createdName=ms5659675100501325, createdTime=Thu Nov 10 11:07:25 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530519, encodeId=48bd5305198f, content=投稿网址能发我一下吗？第一次投外文没经验350779123 2016-03-18 发表:: 研究方向：影像;新技术; 接收率：约50% 审稿时间：约3个月投了一篇，2个月后大修，刚提交了修改稿，虽然审稿人希望提的意见挺难回答的，希望能中~~~, beContent=350779123 2016-03-18 发表:: 研究方向：影像;新技术; 接收率：约50% 审稿时间：约3个月投了一篇，2个月后大修，刚提交了修改稿，虽然审稿人希望提的意见挺难回答的，希望能中~~~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c8825317, createdName=fumingcui, createdTime=Tue Dec 13 11:20:00 CST 2016, time=2016-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086526, encodeId=2b8a108652684, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086525, encodeId=b5bf1086525ad, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978766, encodeId=21589e876627, content=请问各位投稿时的Author disclosures是什么意思呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58865518742, createdName=ms4000001092197071, createdTime=Thu Jul 01 21:14:47 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555987, encodeId=97d455598e9c, content=这篇杂志能共一吗?能有共同通讯吗?zhangxin19830818 2018-04-13 10:15:00 发表: 这个杂志很负责人.对中国学子很友好.我想说我的第一篇SCI文章投的就是这个杂志.2个月被拒了.但是. 一个审稿专家给出了22页的审稿意见.连论文题目都给我重写了.其他精确到每个文字错误.然后改投其同类级别2分多的杂志.直接接受., beContent=zhangxin19830818 2018-04-13 10:15:00 发表: 这个杂志很负责人.对中国学子很友好.我想说我的第一篇SCI文章投的就是这个杂志.2个月被拒了.但是. 一个审稿专家给出了22页的审稿意见.连论文题目都给我重写了.其他精确到每个文字错误.然后改投其同类级别2分多的杂志.直接接受., objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/20/b91b19438f6b5b9d4690ac1c6d87b0b3.jpg, createdBy=e9bd2178983, createdName=阳阳～, createdTime=Fri May 11 00:00:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554930, encodeId=0bd155493050, content=这个杂志很负责人，对中国学子很友好，我想说我的第一篇SCI文章投的就是这个杂志，2个月被拒了，但是，一个审稿专家给出了22页的审稿意见，连论文题目都给我重写了，其他精确到每个文字错误。然后改投其同类级别2分多的杂志，直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/55de70b000754a05b1e4421732bd1c69/6338f0fa024349e1b0ef32e05975b7a6.jpg, createdBy=8f471417716, createdName=zhangxin19830818, createdTime=Fri Apr 13 10:15:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538884, encodeId=d0dc538884d8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿非常慢，投过去后先一个月放那不动；外审一个月；给3个月时间修改，总共5个月接收。 现在接收三个多月了，还没online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eocSnxm7sxxUDwqzdJ3v2akxES9nNYZx70Cy5jLh29SyNnreINBwFwbY3ZOfBF9wSiaiaCnXqddzW1Q/132, createdBy=ae061713092, createdName=Huge502a03ace, createdTime=Tue Jul 18 09:30:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537442, encodeId=267b53e4421c, content=请问，AJR的版面费是多少呢？raindrop 2016-11-16 发表:: 研究方向：基础;; 接收率：约50% 审稿时间：约2个月第一次投稿很幸运的接受了。2个月后初审有结果，大修2次，最终接受一共4个月。专家意见比较中肯，相对友好。感觉偏基础，有一定的新意就可以。, beContent=raindrop 2016-11-16 发表:: 研究方向：基础;; 接收率：约50% 审稿时间：约2个月第一次投稿很幸运的接受了。2个月后初审有结果，大修2次，最终接受一共4个月。专家意见比较中肯，相对友好。感觉偏基础，有一定的新意就可以。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIWznAvf9w9JibPNFEeoqCfBIyP39d1HicA7Bpia7v2ACoE1zDx8xMjD7e26gNNydnwKfrOIT6ycrQUw/0, createdBy=e3842049169, createdName=弥夏兰卡, createdTime=Tue Jun 06 11:55:00 CST 2017, time=2017-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836092, encodeId=9c1d83609247, content=几乎没有什么中国人的文章，不要投了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7055413998, createdName=ms1387707191880519, createdTime=Sat Apr 01 16:03:54 CST 2017, time=2017-04-01, status=1, ipAttribution=)]

2021-12-29 msSSSSSD

如何判断两种药物之间是协同作用还是相加作用？

57 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=834534, encodeId=4825834534fd, content=投稿2个月给意见，修回2个月接收，有点慢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f725414123, createdName=ms5659675100501325, createdTime=Thu Nov 10 11:07:25 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530519, encodeId=48bd5305198f, content=投稿网址能发我一下吗？第一次投外文没经验350779123 2016-03-18 发表:: 研究方向：影像;新技术; 接收率：约50% 审稿时间：约3个月投了一篇，2个月后大修，刚提交了修改稿，虽然审稿人希望提的意见挺难回答的，希望能中~~~, beContent=350779123 2016-03-18 发表:: 研究方向：影像;新技术; 接收率：约50% 审稿时间：约3个月投了一篇，2个月后大修，刚提交了修改稿，虽然审稿人希望提的意见挺难回答的，希望能中~~~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c8825317, createdName=fumingcui, createdTime=Tue Dec 13 11:20:00 CST 2016, time=2016-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086526, encodeId=2b8a108652684, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086525, encodeId=b5bf1086525ad, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978766, encodeId=21589e876627, content=请问各位投稿时的Author disclosures是什么意思呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58865518742, createdName=ms4000001092197071, createdTime=Thu Jul 01 21:14:47 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555987, encodeId=97d455598e9c, content=这篇杂志能共一吗?能有共同通讯吗?zhangxin19830818 2018-04-13 10:15:00 发表: 这个杂志很负责人.对中国学子很友好.我想说我的第一篇SCI文章投的就是这个杂志.2个月被拒了.但是. 一个审稿专家给出了22页的审稿意见.连论文题目都给我重写了.其他精确到每个文字错误.然后改投其同类级别2分多的杂志.直接接受., beContent=zhangxin19830818 2018-04-13 10:15:00 发表: 这个杂志很负责人.对中国学子很友好.我想说我的第一篇SCI文章投的就是这个杂志.2个月被拒了.但是. 一个审稿专家给出了22页的审稿意见.连论文题目都给我重写了.其他精确到每个文字错误.然后改投其同类级别2分多的杂志.直接接受., objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/20/b91b19438f6b5b9d4690ac1c6d87b0b3.jpg, createdBy=e9bd2178983, createdName=阳阳～, createdTime=Fri May 11 00:00:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554930, encodeId=0bd155493050, content=这个杂志很负责人，对中国学子很友好，我想说我的第一篇SCI文章投的就是这个杂志，2个月被拒了，但是，一个审稿专家给出了22页的审稿意见，连论文题目都给我重写了，其他精确到每个文字错误。然后改投其同类级别2分多的杂志，直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/55de70b000754a05b1e4421732bd1c69/6338f0fa024349e1b0ef32e05975b7a6.jpg, createdBy=8f471417716, createdName=zhangxin19830818, createdTime=Fri Apr 13 10:15:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538884, encodeId=d0dc538884d8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿非常慢，投过去后先一个月放那不动；外审一个月；给3个月时间修改，总共5个月接收。 现在接收三个多月了，还没online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eocSnxm7sxxUDwqzdJ3v2akxES9nNYZx70Cy5jLh29SyNnreINBwFwbY3ZOfBF9wSiaiaCnXqddzW1Q/132, createdBy=ae061713092, createdName=Huge502a03ace, createdTime=Tue Jul 18 09:30:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537442, encodeId=267b53e4421c, content=请问，AJR的版面费是多少呢？raindrop 2016-11-16 发表:: 研究方向：基础;; 接收率：约50% 审稿时间：约2个月第一次投稿很幸运的接受了。2个月后初审有结果，大修2次，最终接受一共4个月。专家意见比较中肯，相对友好。感觉偏基础，有一定的新意就可以。, beContent=raindrop 2016-11-16 发表:: 研究方向：基础;; 接收率：约50% 审稿时间：约2个月第一次投稿很幸运的接受了。2个月后初审有结果，大修2次，最终接受一共4个月。专家意见比较中肯，相对友好。感觉偏基础，有一定的新意就可以。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIWznAvf9w9JibPNFEeoqCfBIyP39d1HicA7Bpia7v2ACoE1zDx8xMjD7e26gNNydnwKfrOIT6ycrQUw/0, createdBy=e3842049169, createdName=弥夏兰卡, createdTime=Tue Jun 06 11:55:00 CST 2017, time=2017-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836092, encodeId=9c1d83609247, content=几乎没有什么中国人的文章，不要投了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7055413998, createdName=ms1387707191880519, createdTime=Sat Apr 01 16:03:54 CST 2017, time=2017-04-01, status=1, ipAttribution=)]

2021-12-27 Gym璨烨

上传文章有什么要求？

46 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=834534, encodeId=4825834534fd, content=投稿2个月给意见，修回2个月接收，有点慢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f725414123, createdName=ms5659675100501325, createdTime=Thu Nov 10 11:07:25 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530519, encodeId=48bd5305198f, content=投稿网址能发我一下吗？第一次投外文没经验350779123 2016-03-18 发表:: 研究方向：影像;新技术; 接收率：约50% 审稿时间：约3个月投了一篇，2个月后大修，刚提交了修改稿，虽然审稿人希望提的意见挺难回答的，希望能中~~~, beContent=350779123 2016-03-18 发表:: 研究方向：影像;新技术; 接收率：约50% 审稿时间：约3个月投了一篇，2个月后大修，刚提交了修改稿，虽然审稿人希望提的意见挺难回答的，希望能中~~~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c8825317, createdName=fumingcui, createdTime=Tue Dec 13 11:20:00 CST 2016, time=2016-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086526, encodeId=2b8a108652684, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086525, encodeId=b5bf1086525ad, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978766, encodeId=21589e876627, content=请问各位投稿时的Author disclosures是什么意思呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58865518742, createdName=ms4000001092197071, createdTime=Thu Jul 01 21:14:47 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555987, encodeId=97d455598e9c, content=这篇杂志能共一吗?能有共同通讯吗?zhangxin19830818 2018-04-13 10:15:00 发表: 这个杂志很负责人.对中国学子很友好.我想说我的第一篇SCI文章投的就是这个杂志.2个月被拒了.但是. 一个审稿专家给出了22页的审稿意见.连论文题目都给我重写了.其他精确到每个文字错误.然后改投其同类级别2分多的杂志.直接接受., beContent=zhangxin19830818 2018-04-13 10:15:00 发表: 这个杂志很负责人.对中国学子很友好.我想说我的第一篇SCI文章投的就是这个杂志.2个月被拒了.但是. 一个审稿专家给出了22页的审稿意见.连论文题目都给我重写了.其他精确到每个文字错误.然后改投其同类级别2分多的杂志.直接接受., objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/20/b91b19438f6b5b9d4690ac1c6d87b0b3.jpg, createdBy=e9bd2178983, createdName=阳阳～, createdTime=Fri May 11 00:00:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554930, encodeId=0bd155493050, content=这个杂志很负责人，对中国学子很友好，我想说我的第一篇SCI文章投的就是这个杂志，2个月被拒了，但是，一个审稿专家给出了22页的审稿意见，连论文题目都给我重写了，其他精确到每个文字错误。然后改投其同类级别2分多的杂志，直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/55de70b000754a05b1e4421732bd1c69/6338f0fa024349e1b0ef32e05975b7a6.jpg, createdBy=8f471417716, createdName=zhangxin19830818, createdTime=Fri Apr 13 10:15:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538884, encodeId=d0dc538884d8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿非常慢，投过去后先一个月放那不动；外审一个月；给3个月时间修改，总共5个月接收。 现在接收三个多月了，还没online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eocSnxm7sxxUDwqzdJ3v2akxES9nNYZx70Cy5jLh29SyNnreINBwFwbY3ZOfBF9wSiaiaCnXqddzW1Q/132, createdBy=ae061713092, createdName=Huge502a03ace, createdTime=Tue Jul 18 09:30:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537442, encodeId=267b53e4421c, content=请问，AJR的版面费是多少呢？raindrop 2016-11-16 发表:: 研究方向：基础;; 接收率：约50% 审稿时间：约2个月第一次投稿很幸运的接受了。2个月后初审有结果，大修2次，最终接受一共4个月。专家意见比较中肯，相对友好。感觉偏基础，有一定的新意就可以。, beContent=raindrop 2016-11-16 发表:: 研究方向：基础;; 接收率：约50% 审稿时间：约2个月第一次投稿很幸运的接受了。2个月后初审有结果，大修2次，最终接受一共4个月。专家意见比较中肯，相对友好。感觉偏基础，有一定的新意就可以。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIWznAvf9w9JibPNFEeoqCfBIyP39d1HicA7Bpia7v2ACoE1zDx8xMjD7e26gNNydnwKfrOIT6ycrQUw/0, createdBy=e3842049169, createdName=弥夏兰卡, createdTime=Tue Jun 06 11:55:00 CST 2017, time=2017-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836092, encodeId=9c1d83609247, content=几乎没有什么中国人的文章，不要投了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7055413998, createdName=ms1387707191880519, createdTime=Sat Apr 01 16:03:54 CST 2017, time=2017-04-01, status=1, ipAttribution=)]

2021-07-01 ms4000001092197071

请问各位投稿时的Author disclosures是什么意思呢？

67 0

[GetPortalCommentsPageByObjectIdResponse(id=834534, encodeId=4825834534fd, content=投稿2个月给意见，修回2个月接收，有点慢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f725414123, createdName=ms5659675100501325, createdTime=Thu Nov 10 11:07:25 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530519, encodeId=48bd5305198f, content=投稿网址能发我一下吗？第一次投外文没经验350779123 2016-03-18 发表:: 研究方向：影像;新技术; 接收率：约50% 审稿时间：约3个月投了一篇，2个月后大修，刚提交了修改稿，虽然审稿人希望提的意见挺难回答的，希望能中~~~, beContent=350779123 2016-03-18 发表:: 研究方向：影像;新技术; 接收率：约50% 审稿时间：约3个月投了一篇，2个月后大修，刚提交了修改稿，虽然审稿人希望提的意见挺难回答的，希望能中~~~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c8825317, createdName=fumingcui, createdTime=Tue Dec 13 11:20:00 CST 2016, time=2016-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086526, encodeId=2b8a108652684, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086525, encodeId=b5bf1086525ad, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978766, encodeId=21589e876627, content=请问各位投稿时的Author disclosures是什么意思呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58865518742, createdName=ms4000001092197071, createdTime=Thu Jul 01 21:14:47 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555987, encodeId=97d455598e9c, content=这篇杂志能共一吗?能有共同通讯吗?zhangxin19830818 2018-04-13 10:15:00 发表: 这个杂志很负责人.对中国学子很友好.我想说我的第一篇SCI文章投的就是这个杂志.2个月被拒了.但是. 一个审稿专家给出了22页的审稿意见.连论文题目都给我重写了.其他精确到每个文字错误.然后改投其同类级别2分多的杂志.直接接受., beContent=zhangxin19830818 2018-04-13 10:15:00 发表: 这个杂志很负责人.对中国学子很友好.我想说我的第一篇SCI文章投的就是这个杂志.2个月被拒了.但是. 一个审稿专家给出了22页的审稿意见.连论文题目都给我重写了.其他精确到每个文字错误.然后改投其同类级别2分多的杂志.直接接受., objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/20/b91b19438f6b5b9d4690ac1c6d87b0b3.jpg, createdBy=e9bd2178983, createdName=阳阳～, createdTime=Fri May 11 00:00:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554930, encodeId=0bd155493050, content=这个杂志很负责人，对中国学子很友好，我想说我的第一篇SCI文章投的就是这个杂志，2个月被拒了，但是，一个审稿专家给出了22页的审稿意见，连论文题目都给我重写了，其他精确到每个文字错误。然后改投其同类级别2分多的杂志，直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/55de70b000754a05b1e4421732bd1c69/6338f0fa024349e1b0ef32e05975b7a6.jpg, createdBy=8f471417716, createdName=zhangxin19830818, createdTime=Fri Apr 13 10:15:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538884, encodeId=d0dc538884d8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿非常慢，投过去后先一个月放那不动；外审一个月；给3个月时间修改，总共5个月接收。 现在接收三个多月了，还没online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eocSnxm7sxxUDwqzdJ3v2akxES9nNYZx70Cy5jLh29SyNnreINBwFwbY3ZOfBF9wSiaiaCnXqddzW1Q/132, createdBy=ae061713092, createdName=Huge502a03ace, createdTime=Tue Jul 18 09:30:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537442, encodeId=267b53e4421c, content=请问，AJR的版面费是多少呢？raindrop 2016-11-16 发表:: 研究方向：基础;; 接收率：约50% 审稿时间：约2个月第一次投稿很幸运的接受了。2个月后初审有结果，大修2次，最终接受一共4个月。专家意见比较中肯，相对友好。感觉偏基础，有一定的新意就可以。, beContent=raindrop 2016-11-16 发表:: 研究方向：基础;; 接收率：约50% 审稿时间：约2个月第一次投稿很幸运的接受了。2个月后初审有结果，大修2次，最终接受一共4个月。专家意见比较中肯，相对友好。感觉偏基础，有一定的新意就可以。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIWznAvf9w9JibPNFEeoqCfBIyP39d1HicA7Bpia7v2ACoE1zDx8xMjD7e26gNNydnwKfrOIT6ycrQUw/0, createdBy=e3842049169, createdName=弥夏兰卡, createdTime=Tue Jun 06 11:55:00 CST 2017, time=2017-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836092, encodeId=9c1d83609247, content=几乎没有什么中国人的文章，不要投了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7055413998, createdName=ms1387707191880519, createdTime=Sat Apr 01 16:03:54 CST 2017, time=2017-04-01, status=1, ipAttribution=)]

2018-05-11 阳阳～

这篇杂志能共一吗?能有共同通讯吗?zhangxin19830818 2018-04-13 10:15:00 发表:
这个杂志很负责人.对中国学子很友好.我想说我的第一篇SCI文章投的就是这个杂志.2个月被拒了.但是. 一个审稿专家给出了22页的审稿意见.连论文题目都给我重写了.其他精确到每个文字错误.然后改投其同类级别2分多的杂志.直接接受.

zhangxin19830818 2018-04-13 10:15:00 发表: 这个杂志很负责人.对中国学子很友好.我想说我的第一篇SCI文章投的就是这个杂志.2个月被拒了.但是. 一个审稿专家给出了22页的审稿意见.连论文题目都给我重写了.其他精确到每个文字错误.然后改投其同类级别2分多的杂志.直接接受.

378 0

[GetPortalCommentsPageByObjectIdResponse(id=834534, encodeId=4825834534fd, content=投稿2个月给意见，修回2个月接收，有点慢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f725414123, createdName=ms5659675100501325, createdTime=Thu Nov 10 11:07:25 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530519, encodeId=48bd5305198f, content=投稿网址能发我一下吗？第一次投外文没经验350779123 2016-03-18 发表:: 研究方向：影像;新技术; 接收率：约50% 审稿时间：约3个月投了一篇，2个月后大修，刚提交了修改稿，虽然审稿人希望提的意见挺难回答的，希望能中~~~, beContent=350779123 2016-03-18 发表:: 研究方向：影像;新技术; 接收率：约50% 审稿时间：约3个月投了一篇，2个月后大修，刚提交了修改稿，虽然审稿人希望提的意见挺难回答的，希望能中~~~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c8825317, createdName=fumingcui, createdTime=Tue Dec 13 11:20:00 CST 2016, time=2016-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086526, encodeId=2b8a108652684, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086525, encodeId=b5bf1086525ad, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978766, encodeId=21589e876627, content=请问各位投稿时的Author disclosures是什么意思呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58865518742, createdName=ms4000001092197071, createdTime=Thu Jul 01 21:14:47 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555987, encodeId=97d455598e9c, content=这篇杂志能共一吗?能有共同通讯吗?zhangxin19830818 2018-04-13 10:15:00 发表: 这个杂志很负责人.对中国学子很友好.我想说我的第一篇SCI文章投的就是这个杂志.2个月被拒了.但是. 一个审稿专家给出了22页的审稿意见.连论文题目都给我重写了.其他精确到每个文字错误.然后改投其同类级别2分多的杂志.直接接受., beContent=zhangxin19830818 2018-04-13 10:15:00 发表: 这个杂志很负责人.对中国学子很友好.我想说我的第一篇SCI文章投的就是这个杂志.2个月被拒了.但是. 一个审稿专家给出了22页的审稿意见.连论文题目都给我重写了.其他精确到每个文字错误.然后改投其同类级别2分多的杂志.直接接受., objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/20/b91b19438f6b5b9d4690ac1c6d87b0b3.jpg, createdBy=e9bd2178983, createdName=阳阳～, createdTime=Fri May 11 00:00:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554930, encodeId=0bd155493050, content=这个杂志很负责人，对中国学子很友好，我想说我的第一篇SCI文章投的就是这个杂志，2个月被拒了，但是，一个审稿专家给出了22页的审稿意见，连论文题目都给我重写了，其他精确到每个文字错误。然后改投其同类级别2分多的杂志，直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/55de70b000754a05b1e4421732bd1c69/6338f0fa024349e1b0ef32e05975b7a6.jpg, createdBy=8f471417716, createdName=zhangxin19830818, createdTime=Fri Apr 13 10:15:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538884, encodeId=d0dc538884d8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿非常慢，投过去后先一个月放那不动；外审一个月；给3个月时间修改，总共5个月接收。 现在接收三个多月了，还没online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eocSnxm7sxxUDwqzdJ3v2akxES9nNYZx70Cy5jLh29SyNnreINBwFwbY3ZOfBF9wSiaiaCnXqddzW1Q/132, createdBy=ae061713092, createdName=Huge502a03ace, createdTime=Tue Jul 18 09:30:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537442, encodeId=267b53e4421c, content=请问，AJR的版面费是多少呢？raindrop 2016-11-16 发表:: 研究方向：基础;; 接收率：约50% 审稿时间：约2个月第一次投稿很幸运的接受了。2个月后初审有结果，大修2次，最终接受一共4个月。专家意见比较中肯，相对友好。感觉偏基础，有一定的新意就可以。, beContent=raindrop 2016-11-16 发表:: 研究方向：基础;; 接收率：约50% 审稿时间：约2个月第一次投稿很幸运的接受了。2个月后初审有结果，大修2次，最终接受一共4个月。专家意见比较中肯，相对友好。感觉偏基础，有一定的新意就可以。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIWznAvf9w9JibPNFEeoqCfBIyP39d1HicA7Bpia7v2ACoE1zDx8xMjD7e26gNNydnwKfrOIT6ycrQUw/0, createdBy=e3842049169, createdName=弥夏兰卡, createdTime=Tue Jun 06 11:55:00 CST 2017, time=2017-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836092, encodeId=9c1d83609247, content=几乎没有什么中国人的文章，不要投了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7055413998, createdName=ms1387707191880519, createdTime=Sat Apr 01 16:03:54 CST 2017, time=2017-04-01, status=1, ipAttribution=)]

2018-04-13 zhangxin19830818

这个杂志很负责人，对中国学子很友好，我想说我的第一篇SCI文章投的就是这个杂志，2个月被拒了，但是，一个审稿专家给出了22页的审稿意见，连论文题目都给我重写了，其他精确到每个文字错误。然后改投其同类级别2分多的杂志，直接接受。

384 0

[GetPortalCommentsPageByObjectIdResponse(id=834534, encodeId=4825834534fd, content=投稿2个月给意见，修回2个月接收，有点慢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f725414123, createdName=ms5659675100501325, createdTime=Thu Nov 10 11:07:25 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530519, encodeId=48bd5305198f, content=投稿网址能发我一下吗？第一次投外文没经验350779123 2016-03-18 发表:: 研究方向：影像;新技术; 接收率：约50% 审稿时间：约3个月投了一篇，2个月后大修，刚提交了修改稿，虽然审稿人希望提的意见挺难回答的，希望能中~~~, beContent=350779123 2016-03-18 发表:: 研究方向：影像;新技术; 接收率：约50% 审稿时间：约3个月投了一篇，2个月后大修，刚提交了修改稿，虽然审稿人希望提的意见挺难回答的，希望能中~~~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c8825317, createdName=fumingcui, createdTime=Tue Dec 13 11:20:00 CST 2016, time=2016-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086526, encodeId=2b8a108652684, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086525, encodeId=b5bf1086525ad, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978766, encodeId=21589e876627, content=请问各位投稿时的Author disclosures是什么意思呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58865518742, createdName=ms4000001092197071, createdTime=Thu Jul 01 21:14:47 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555987, encodeId=97d455598e9c, content=这篇杂志能共一吗?能有共同通讯吗?zhangxin19830818 2018-04-13 10:15:00 发表: 这个杂志很负责人.对中国学子很友好.我想说我的第一篇SCI文章投的就是这个杂志.2个月被拒了.但是. 一个审稿专家给出了22页的审稿意见.连论文题目都给我重写了.其他精确到每个文字错误.然后改投其同类级别2分多的杂志.直接接受., beContent=zhangxin19830818 2018-04-13 10:15:00 发表: 这个杂志很负责人.对中国学子很友好.我想说我的第一篇SCI文章投的就是这个杂志.2个月被拒了.但是. 一个审稿专家给出了22页的审稿意见.连论文题目都给我重写了.其他精确到每个文字错误.然后改投其同类级别2分多的杂志.直接接受., objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/20/b91b19438f6b5b9d4690ac1c6d87b0b3.jpg, createdBy=e9bd2178983, createdName=阳阳～, createdTime=Fri May 11 00:00:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554930, encodeId=0bd155493050, content=这个杂志很负责人，对中国学子很友好，我想说我的第一篇SCI文章投的就是这个杂志，2个月被拒了，但是，一个审稿专家给出了22页的审稿意见，连论文题目都给我重写了，其他精确到每个文字错误。然后改投其同类级别2分多的杂志，直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/55de70b000754a05b1e4421732bd1c69/6338f0fa024349e1b0ef32e05975b7a6.jpg, createdBy=8f471417716, createdName=zhangxin19830818, createdTime=Fri Apr 13 10:15:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538884, encodeId=d0dc538884d8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿非常慢，投过去后先一个月放那不动；外审一个月；给3个月时间修改，总共5个月接收。 现在接收三个多月了，还没online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eocSnxm7sxxUDwqzdJ3v2akxES9nNYZx70Cy5jLh29SyNnreINBwFwbY3ZOfBF9wSiaiaCnXqddzW1Q/132, createdBy=ae061713092, createdName=Huge502a03ace, createdTime=Tue Jul 18 09:30:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537442, encodeId=267b53e4421c, content=请问，AJR的版面费是多少呢？raindrop 2016-11-16 发表:: 研究方向：基础;; 接收率：约50% 审稿时间：约2个月第一次投稿很幸运的接受了。2个月后初审有结果，大修2次，最终接受一共4个月。专家意见比较中肯，相对友好。感觉偏基础，有一定的新意就可以。, beContent=raindrop 2016-11-16 发表:: 研究方向：基础;; 接收率：约50% 审稿时间：约2个月第一次投稿很幸运的接受了。2个月后初审有结果，大修2次，最终接受一共4个月。专家意见比较中肯，相对友好。感觉偏基础，有一定的新意就可以。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIWznAvf9w9JibPNFEeoqCfBIyP39d1HicA7Bpia7v2ACoE1zDx8xMjD7e26gNNydnwKfrOIT6ycrQUw/0, createdBy=e3842049169, createdName=弥夏兰卡, createdTime=Tue Jun 06 11:55:00 CST 2017, time=2017-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836092, encodeId=9c1d83609247, content=几乎没有什么中国人的文章，不要投了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7055413998, createdName=ms1387707191880519, createdTime=Sat Apr 01 16:03:54 CST 2017, time=2017-04-01, status=1, ipAttribution=)]

2017-07-18 Huge502a03ace

审稿速度:3.0 | 投稿命中率:25.0
经验分享：审稿非常慢，投过去后先一个月放那不动；外审一个月；给3个月时间修改，总共5个月接收。
现在接收三个多月了，还没online。

279 0

[GetPortalCommentsPageByObjectIdResponse(id=834534, encodeId=4825834534fd, content=投稿2个月给意见，修回2个月接收，有点慢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f725414123, createdName=ms5659675100501325, createdTime=Thu Nov 10 11:07:25 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530519, encodeId=48bd5305198f, content=投稿网址能发我一下吗？第一次投外文没经验350779123 2016-03-18 发表:: 研究方向：影像;新技术; 接收率：约50% 审稿时间：约3个月投了一篇，2个月后大修，刚提交了修改稿，虽然审稿人希望提的意见挺难回答的，希望能中~~~, beContent=350779123 2016-03-18 发表:: 研究方向：影像;新技术; 接收率：约50% 审稿时间：约3个月投了一篇，2个月后大修，刚提交了修改稿，虽然审稿人希望提的意见挺难回答的，希望能中~~~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c8825317, createdName=fumingcui, createdTime=Tue Dec 13 11:20:00 CST 2016, time=2016-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086526, encodeId=2b8a108652684, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086525, encodeId=b5bf1086525ad, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978766, encodeId=21589e876627, content=请问各位投稿时的Author disclosures是什么意思呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58865518742, createdName=ms4000001092197071, createdTime=Thu Jul 01 21:14:47 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555987, encodeId=97d455598e9c, content=这篇杂志能共一吗?能有共同通讯吗?zhangxin19830818 2018-04-13 10:15:00 发表: 这个杂志很负责人.对中国学子很友好.我想说我的第一篇SCI文章投的就是这个杂志.2个月被拒了.但是. 一个审稿专家给出了22页的审稿意见.连论文题目都给我重写了.其他精确到每个文字错误.然后改投其同类级别2分多的杂志.直接接受., beContent=zhangxin19830818 2018-04-13 10:15:00 发表: 这个杂志很负责人.对中国学子很友好.我想说我的第一篇SCI文章投的就是这个杂志.2个月被拒了.但是. 一个审稿专家给出了22页的审稿意见.连论文题目都给我重写了.其他精确到每个文字错误.然后改投其同类级别2分多的杂志.直接接受., objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/20/b91b19438f6b5b9d4690ac1c6d87b0b3.jpg, createdBy=e9bd2178983, createdName=阳阳～, createdTime=Fri May 11 00:00:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554930, encodeId=0bd155493050, content=这个杂志很负责人，对中国学子很友好，我想说我的第一篇SCI文章投的就是这个杂志，2个月被拒了，但是，一个审稿专家给出了22页的审稿意见，连论文题目都给我重写了，其他精确到每个文字错误。然后改投其同类级别2分多的杂志，直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/55de70b000754a05b1e4421732bd1c69/6338f0fa024349e1b0ef32e05975b7a6.jpg, createdBy=8f471417716, createdName=zhangxin19830818, createdTime=Fri Apr 13 10:15:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538884, encodeId=d0dc538884d8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿非常慢，投过去后先一个月放那不动；外审一个月；给3个月时间修改，总共5个月接收。 现在接收三个多月了，还没online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eocSnxm7sxxUDwqzdJ3v2akxES9nNYZx70Cy5jLh29SyNnreINBwFwbY3ZOfBF9wSiaiaCnXqddzW1Q/132, createdBy=ae061713092, createdName=Huge502a03ace, createdTime=Tue Jul 18 09:30:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537442, encodeId=267b53e4421c, content=请问，AJR的版面费是多少呢？raindrop 2016-11-16 发表:: 研究方向：基础;; 接收率：约50% 审稿时间：约2个月第一次投稿很幸运的接受了。2个月后初审有结果，大修2次，最终接受一共4个月。专家意见比较中肯，相对友好。感觉偏基础，有一定的新意就可以。, beContent=raindrop 2016-11-16 发表:: 研究方向：基础;; 接收率：约50% 审稿时间：约2个月第一次投稿很幸运的接受了。2个月后初审有结果，大修2次，最终接受一共4个月。专家意见比较中肯，相对友好。感觉偏基础，有一定的新意就可以。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIWznAvf9w9JibPNFEeoqCfBIyP39d1HicA7Bpia7v2ACoE1zDx8xMjD7e26gNNydnwKfrOIT6ycrQUw/0, createdBy=e3842049169, createdName=弥夏兰卡, createdTime=Tue Jun 06 11:55:00 CST 2017, time=2017-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836092, encodeId=9c1d83609247, content=几乎没有什么中国人的文章，不要投了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7055413998, createdName=ms1387707191880519, createdTime=Sat Apr 01 16:03:54 CST 2017, time=2017-04-01, status=1, ipAttribution=)]

2017-06-06 弥夏兰卡

请问，AJR的版面费是多少呢？raindrop 2016-11-16 发表::
研究方向：基础;; 接收率：约50% 审稿时间：约2个月第一次投稿很幸运的接受了。2个月后初审有结果，大修2次，最终接受一共4个月。专家意见比较中肯，相对友好。感觉偏基础，有一定的新意就可以。

raindrop 2016-11-16 发表:: 研究方向：基础;; 接收率：约50% 审稿时间：约2个月第一次投稿很幸运的接受了。2个月后初审有结果，大修2次，最终接受一共4个月。专家意见比较中肯，相对友好。感觉偏基础，有一定的新意就可以。

304 0

[GetPortalCommentsPageByObjectIdResponse(id=834534, encodeId=4825834534fd, content=投稿2个月给意见，修回2个月接收，有点慢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f725414123, createdName=ms5659675100501325, createdTime=Thu Nov 10 11:07:25 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530519, encodeId=48bd5305198f, content=投稿网址能发我一下吗？第一次投外文没经验350779123 2016-03-18 发表:: 研究方向：影像;新技术; 接收率：约50% 审稿时间：约3个月投了一篇，2个月后大修，刚提交了修改稿，虽然审稿人希望提的意见挺难回答的，希望能中~~~, beContent=350779123 2016-03-18 发表:: 研究方向：影像;新技术; 接收率：约50% 审稿时间：约3个月投了一篇，2个月后大修，刚提交了修改稿，虽然审稿人希望提的意见挺难回答的，希望能中~~~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=366, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c8825317, createdName=fumingcui, createdTime=Tue Dec 13 11:20:00 CST 2016, time=2016-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086526, encodeId=2b8a108652684, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086525, encodeId=b5bf1086525ad, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978766, encodeId=21589e876627, content=请问各位投稿时的Author disclosures是什么意思呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58865518742, createdName=ms4000001092197071, createdTime=Thu Jul 01 21:14:47 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555987, encodeId=97d455598e9c, content=这篇杂志能共一吗?能有共同通讯吗?zhangxin19830818 2018-04-13 10:15:00 发表: 这个杂志很负责人.对中国学子很友好.我想说我的第一篇SCI文章投的就是这个杂志.2个月被拒了.但是. 一个审稿专家给出了22页的审稿意见.连论文题目都给我重写了.其他精确到每个文字错误.然后改投其同类级别2分多的杂志.直接接受., beContent=zhangxin19830818 2018-04-13 10:15:00 发表: 这个杂志很负责人.对中国学子很友好.我想说我的第一篇SCI文章投的就是这个杂志.2个月被拒了.但是. 一个审稿专家给出了22页的审稿意见.连论文题目都给我重写了.其他精确到每个文字错误.然后改投其同类级别2分多的杂志.直接接受., objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/20/b91b19438f6b5b9d4690ac1c6d87b0b3.jpg, createdBy=e9bd2178983, createdName=阳阳～, createdTime=Fri May 11 00:00:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554930, encodeId=0bd155493050, content=这个杂志很负责人，对中国学子很友好，我想说我的第一篇SCI文章投的就是这个杂志，2个月被拒了，但是，一个审稿专家给出了22页的审稿意见，连论文题目都给我重写了，其他精确到每个文字错误。然后改投其同类级别2分多的杂志，直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=384, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/55de70b000754a05b1e4421732bd1c69/6338f0fa024349e1b0ef32e05975b7a6.jpg, createdBy=8f471417716, createdName=zhangxin19830818, createdTime=Fri Apr 13 10:15:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538884, encodeId=d0dc538884d8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：审稿非常慢，投过去后先一个月放那不动；外审一个月；给3个月时间修改，总共5个月接收。 现在接收三个多月了，还没online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eocSnxm7sxxUDwqzdJ3v2akxES9nNYZx70Cy5jLh29SyNnreINBwFwbY3ZOfBF9wSiaiaCnXqddzW1Q/132, createdBy=ae061713092, createdName=Huge502a03ace, createdTime=Tue Jul 18 09:30:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537442, encodeId=267b53e4421c, content=请问，AJR的版面费是多少呢？raindrop 2016-11-16 发表:: 研究方向：基础;; 接收率：约50% 审稿时间：约2个月第一次投稿很幸运的接受了。2个月后初审有结果，大修2次，最终接受一共4个月。专家意见比较中肯，相对友好。感觉偏基础，有一定的新意就可以。, beContent=raindrop 2016-11-16 发表:: 研究方向：基础;; 接收率：约50% 审稿时间：约2个月第一次投稿很幸运的接受了。2个月后初审有结果，大修2次，最终接受一共4个月。专家意见比较中肯，相对友好。感觉偏基础，有一定的新意就可以。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIWznAvf9w9JibPNFEeoqCfBIyP39d1HicA7Bpia7v2ACoE1zDx8xMjD7e26gNNydnwKfrOIT6ycrQUw/0, createdBy=e3842049169, createdName=弥夏兰卡, createdTime=Tue Jun 06 11:55:00 CST 2017, time=2017-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836092, encodeId=9c1d83609247, content=几乎没有什么中国人的文章，不要投了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7055413998, createdName=ms1387707191880519, createdTime=Sat Apr 01 16:03:54 CST 2017, time=2017-04-01, status=1, ipAttribution=)]

2017-04-01 ms1387707191880519

几乎没有什么中国人的文章，不要投了

113 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务